Literature DB >> 7200840

Hydrocortisone reverses the suppression of immunoglobulin synthesis by concanavalin A-activated spleen cell supernatants.

D Ilfeld, R S Krakauer.   

Abstract

Supernatants of concanavalin A (Con A)-activated human spleen cells have been previously shown to inhibit polyclonal immunoglobulin (Ig) biosynthesis by pokeweed mitogen (PWM)-stimulated human spleen and peripheral blood mononuclear cells. In the present study, hydrocortisone was added at the beginning of in vitro culture to determine whether it might influence the immunoregulation of polyclonal IgG, IgA and IgM biosynthesis by PWM-stimulated human spleen and peripheral blood mononuclear cells. Hydrocortisone (10(-5) m) mildly increased (15 +/- 9%; mean +/- s.e.m.) polyclonal Ig biosynthesis when added to PWM-stimulated human mononuclear cells. The addition of supernatants from Con A-activated human spleen cells to PWM-stimulated human spleen and peripheral blood mononuclear cells significantly (P less than 0 . 001) suppressed (94 +/- 2%) polyclonal Ig biosynthesis. In contrast, when hydrocortisone (10(-5) m) was added together with Con A supernatants to PWM-stimulated cells, there was no significant suppression (6 +/- 13%) of polyclonal Ig synthesis. Thus, one mechanism by which hydrocortisone can influence Ig biosynthesis is by blocking the suppressive effect of a soluble suppressor factor secreted by Con A-activated human spleen cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7200840      PMCID: PMC1536576     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Site of action of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells.

Authors:  T Tadakuma; C W Pierce
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

2.  Biological expressions of lymphocyte activation. 3. Suppression of plaque-forming cell responses in vitro by supernatant fluids from concanavalin A-activated spleen cell cultures.

Authors:  R R Rich; C W Pierce
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

3.  Immunoglobulin E in immunologic deficiency diseases. II. Serum IgE concentration of patients with acquired hypogammaglobulinemia, thymoma and hypogammaglobulinemia, myotonic dystrophy, intestinal lymphangiectasia and Wiskott-Aldrich syndrome.

Authors:  T A Waldmann; S H Polmar; S T Balestra; M C Jost; R M Bruce; W D Terry
Journal:  J Immunol       Date:  1972-08       Impact factor: 5.422

4.  Control of human B lymphocyte responsiveness: enhanced suppressor T cell activity after in vitro incubation.

Authors:  P E Lipsky; W W Ginsburg; F D Finkelman; M Ziff
Journal:  J Immunol       Date:  1978-03       Impact factor: 5.422

5.  Therapeutic studies in NZB/NZW mice. VI. Age-dependent effects of concanavalin A stimulated spleen cell supernate.

Authors:  A D Steinberg; R Krakauer; J L Reinertsen; L W Klassen; D Ilfeld; J P Reeves; G W Williams; T Antonovych
Journal:  Arthritis Rheum       Date:  1978-03

6.  The role of suppressor cells in the pathogenesis of common variable hypogammaglobulinemia and the immunodeficiency associated with myeloma.

Authors:  T A Waldmann; S Broder; R Krakauer; R P MacDermott; M Durm; C Goldman; B Meade
Journal:  Fed Proc       Date:  1976-07

7.  Activation of human B lymphocytes. IV. Regulatory effects of corticosteroids on the triggering signal in the plaque-forming cell response of human peripheral blood B lymphocytes to polyclonal activation.

Authors:  A S Fauci; K R Pratt; G Whalen
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

Review 8.  Glucocorticosteroid therapy: mechanisms of action and clinical considerations.

Authors:  A S Fauci; D C Dale; J E Balow
Journal:  Ann Intern Med       Date:  1976-03       Impact factor: 25.391

9.  Biological expressions of lymphocyte activation. II. Generation of a population of thymus-derived suppressor lymphocytes.

Authors:  R R Rich; C W Pierce
Journal:  J Exp Med       Date:  1973-03-01       Impact factor: 14.307

10.  Inhibitory and stimulatory effects of concanavalin A on the response of mouse spleen cell suspensions to antigen. I. Characterization of the inhibitory cell activity.

Authors:  R W Dutton
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more
  2 in total

1.  IgG production in 'autoimmune' chronic active hepatitis. Effect of prednisolone on T and B lymphocyte function.

Authors:  K T Nouri-Aria; J E Hegarty; G J Alexander; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

2.  Spontaneous and Concanavalin A-induced suppressor activity in control and Hodgkin's disease patients.

Authors:  A N Akbar; D B Jones; D H Wright
Journal:  Br J Cancer       Date:  1984-03       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.